Increased Guidance for 2024
Healthpeak increased guidance for the third time this year, driven by outperformance in leasing, same-store operations, and merger synergies.
Merger Synergies Outperformance
Year one synergies from the merger are tracking to be $50 million, 25% above the initial forecast, with additional synergies expected in the next year or two.
Strong Leasing Momentum
Over 700,000 square feet of leases signed since July 1, with positive 10% cash re-leasing spreads in the third quarter.
High Dividends and Free Cash Flow
Paying a 5%-plus dividend with a conservative payout ratio, leaving nearly $300 million of annual free cash flow to reinvest in the business.
Outpatient Medical Business Growth
Record re-leasing spreads and moving rent escalators up to 3% on new leases, with over 5 million square feet of leases executed year-to-date.
Balance Sheet Strength
Net debt-to-EBITDA of 5.1 times and $3 billion of liquidity, with the revolver being completely undrawn.